Efficacy and safety of vinorelbine plus cisplatin chemotherapy for patients with recurrent and/or metastatic salivary gland cancer of the head and neck
ConclusionAdministering vinorelbine plus cisplatin chemotherapy to patients with recurrent and/or metastatic salivary gland cancers is safe and effective.
Source: Head and Neck - Category: ENT & OMF Authors: Min Hee Hong, Chang Gon Kim, Yoon Woo Koh, Eun Chang Choi, Jinna Kim, Sun Och Yoon, Hye Ryun Kim, Byoung Chul Cho Tags: ORIGINAL ARTICLE Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | ENT & OMF | Head and Neck Cancer | Salivary Gland Cancer | Study